Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
KRW 3770.0
(-1.31%)
KRW 3770.0
(-1.31%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -90.70 KRW | 1.66% |
| 2022 | -92.23 KRW | 50.02% |
| 2021 | -184.52 KRW | 69.24% |
| 2020 | -599.87 KRW | -64.99% |
| 2019 | -363.57 KRW | -24.09% |
| 2018 | -293.00 KRW | -2830.0% |
| 2017 | -10.00 KRW | 87.99% |
| 2016 | -83.29 KRW | -462.13% |
| 2015 | 23.00 KRW | 103.9% |
| 2014 | -589.00 KRW | -435.45% |
| 2013 | -110.00 KRW | -160.77% |
| 2012 | 181.00 KRW | 88.54% |
| 2011 | 96.00 KRW | 121.77% |
| 2010 | -441.00 KRW | -1522.58% |
| 2009 | 31.00 KRW | -84.58% |
| 2008 | 201.00 KRW | 31.72% |
| 2007 | 152.60 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -7.15 KRW | 91.78% |
| 2024 Q2 | -46.36 KRW | -548.39% |
| 2023 Q2 | -35.55 KRW | -205.36% |
| 2023 Q1 | 33.74 KRW | 221.98% |
| 2023 Q4 | -86.94 KRW | -4358.46% |
| 2023 FY | - KRW | 1.66% |
| 2023 Q3 | -1.95 KRW | 94.51% |
| 2022 Q3 | 60.00 KRW | 195.24% |
| 2022 Q4 | -27.66 KRW | -146.1% |
| 2022 FY | - KRW | 50.02% |
| 2022 Q1 | -62.00 KRW | 34.4% |
| 2022 Q2 | -63.00 KRW | -1.61% |
| 2021 Q3 | -22.00 KRW | -340.0% |
| 2021 Q4 | -94.51 KRW | -329.59% |
| 2021 Q1 | -30.35 KRW | 89.12% |
| 2021 Q2 | -5.00 KRW | 83.53% |
| 2021 FY | - KRW | 69.24% |
| 2020 Q1 | -216.36 KRW | -6.22% |
| 2020 FY | - KRW | -64.99% |
| 2020 Q2 | 2.00 KRW | 100.92% |
| 2020 Q3 | -107.00 KRW | -5450.0% |
| 2020 Q4 | -278.90 KRW | -160.65% |
| 2019 Q3 | 11.00 KRW | 110.89% |
| 2019 Q2 | -101.00 KRW | -44.29% |
| 2019 Q1 | -70.00 KRW | -124.97% |
| 2019 FY | - KRW | -24.09% |
| 2019 Q4 | -203.70 KRW | -1951.82% |
| 2018 FY | - KRW | -2830.0% |
| 2018 Q2 | 55.47 KRW | 305.44% |
| 2018 Q4 | 280.31 KRW | 149.44% |
| 2018 Q1 | -27.00 KRW | 48.34% |
| 2018 Q3 | -567.00 KRW | -1122.17% |
| 2017 FY | - KRW | 87.99% |
| 2017 Q2 | 10.87 KRW | -16.38% |
| 2017 Q1 | 13.00 KRW | 86.78% |
| 2017 Q4 | -52.26 KRW | -293.56% |
| 2017 Q3 | 27.00 KRW | 148.39% |
| 2016 Q3 | -34.00 KRW | 47.2% |
| 2016 FY | - KRW | -462.13% |
| 2016 Q4 | 6.96 KRW | 120.47% |
| 2016 Q1 | 8.00 KRW | 173.94% |
| 2016 Q2 | -64.39 KRW | -904.88% |
| 2015 FY | - KRW | 103.9% |
| 2015 Q4 | -10.82 KRW | 62.53% |
| 2015 Q3 | -28.88 KRW | -312.04% |
| 2015 Q2 | 13.62 KRW | -72.76% |
| 2015 Q1 | 50.00 KRW | 108.05% |
| 2014 FY | - KRW | -435.45% |
| 2014 Q2 | 8.00 KRW | -33.33% |
| 2014 Q4 | -621.12 KRW | -8539.13% |
| 2014 Q3 | 7.36 KRW | -8.0% |
| 2014 Q1 | 12.00 KRW | 109.7% |
| 2013 Q1 | 41.00 KRW | 424.11% |
| 2013 Q2 | -5.00 KRW | -112.2% |
| 2013 Q3 | -21.40 KRW | -328.0% |
| 2013 FY | - KRW | -160.77% |
| 2013 Q4 | -123.74 KRW | -478.22% |
| 2012 Q4 | -12.65 KRW | -199.29% |
| 2012 Q3 | 12.74 KRW | -85.19% |
| 2012 Q2 | 86.00 KRW | -1.15% |
| 2012 Q1 | 87.00 KRW | 1187.5% |
| 2012 FY | - KRW | 88.54% |
| 2011 Q4 | -8.00 KRW | -136.36% |
| 2011 FY | - KRW | 121.77% |
| 2011 Q3 | 22.00 KRW | -59.26% |
| 2011 Q2 | 54.00 KRW | 45.95% |
| 2011 Q1 | 37.00 KRW | 107.35% |
| 2010 Q3 | 3.00 KRW | 123.08% |
| 2010 FY | - KRW | -1522.58% |
| 2010 Q4 | -503.53 KRW | -16884.33% |
| 2010 Q1 | -7.00 KRW | 68.23% |
| 2010 Q2 | -13.00 KRW | -85.71% |
| 2009 Q3 | 10.00 KRW | -9.09% |
| 2009 Q1 | 32.00 KRW | 135.11% |
| 2009 FY | - KRW | -84.58% |
| 2009 Q2 | 11.00 KRW | -65.63% |
| 2009 Q4 | -22.03 KRW | -320.3% |
| 2008 Q2 | 81.40 KRW | -66.0% |
| 2008 Q1 | 239.40 KRW | 383.95% |
| 2008 FY | - KRW | 31.72% |
| 2008 Q4 | -91.14 KRW | -225.5% |
| 2008 Q3 | -28.00 KRW | -134.4% |
| 2007 Q1 | 43.28 KRW | 0.0% |
| 2007 Q4 | -84.31 KRW | -908.34% |
| 2007 FY | - KRW | 0.0% |
| 2007 Q2 | 185.60 KRW | 328.84% |
| 2007 Q3 | 10.43 KRW | -94.38% |